3sfi | pdb_00003sfi
From Proteopedia
Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors.
About this Structure
3sfi is a 1 chain structure with sequence from Mycobacterium tuberculosis. Full crystallographic information is available from OCA.
Reference
- Flipo M, Desroses M, Lecat-Guillet N, Villemagne B, Blondiaux N, Leroux F, Piveteau C, Mathys V, Flament MP, Siepmann J, Villeret V, Wohlkonig A, Wintjens R, Soror SH, Christophe T, Jeon HK, Locht C, Brodin P, Deprez BP, Baulard A, Willand N. Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors. J Med Chem. 2011 Nov 20. PMID:22098589 doi:10.1021/jm200825u
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Pages with broken file links
- Mycobacterium tuberculosis
- Baulard, A R.
- Blondiaux, N.
- Brodin, P.
- Christophe, T.
- Desroses, M.
- Flament, M P.
- Flipo, M.
- Jeon, H K.
- Lecat-Guillet, N.
- Leroux, F.
- Locht, C.
- Mathys, V.
- Piveteau, C.
- Siepmann, J.
- Soror, S H.
- Villemagne, B.
- Villeret, V.
- Willand, N
- Wintjens, R.
- Wohlkonig, A.
- Prez, BD.
- Dna
- Dna binding protein
- Inhibitor
- Tetr-family
- Transcription repressor-inhibitor complex
- Transcritptional regulatory repressor
